Vaccination remains the strongest defense against COVID-19. For more information about where you can schedule a vaccine, be tested for COVID-19 or learn more about the virus, visit https://www.bjc.org/coronavirus
In addition to mavacamten, the Hypertrophic Cardiomyopathy Center offers people with HCM a range of medical, interventional and surgical options.
An estimated 1 million people in the U.S. have hypertrophic cardiomyopathy—a heart condition also known as HCM—and many don’t know they have the condition until it’s too late.
As an inherited disease, HCM can run in families—and it can develop at any age. In many instances, HCM is undiagnosed until a significant heart problem occurs.
A team of Washington University physicians at Barnes-Jewish Hospital is participating in a clinical investigation of a transcatheter mitral valve replacement (TMVR) system that offers an alternative to patients who are too high risk for replacement surgery.
Puja Kachroo, MD replaces Dr. Marc Moon as the Surgical Director of the Center for Diseases of the Thoracic Aorta at the Washington University and Barnes-Jewish Heart & Vascular Center.